Pharmaceutical Research and Manufacturers of America California Initiative Fund
Pharmaceutical Research and Manufacturers of America California Initiative Fund is a political services vendor. In the 2025-2026 cycle Pharmaceutical Research and Manufacturers of America California Initiative Fund was paid $183.61M across 3 client committees, of which $99.45M flowed through Independent Expenditures rather than direct committee payments.
Part I Identity
Stable facts about this entity. These figures do not change as you adjust the timeframe in Part II.
Source split
| Schedule B direct committee payments |
$84,163,300 | 95 rows | 45.8% |
| Independent Expenditures money this entity spent supporting candidates, NOT a committee paying them |
$99,446,295 | 109 rows | 54.2% |
- Activity span ALL TIME
- Feb 8, 2005 → May 8, 2026
- spans 21.2 years
- Disbursements ALL TIME
- 95
- Schedule B + IE rows
- Client committees ALL TIME
- 3
- distinct payers
Part II Activity in selected window
One timeframe control governs all three panels below. Change it once and the trajectory, top buyers, and party breakdown all update together.
Spend trajectory
Monthly spend to this vendor over the last 12 months.
Top buyers
Two views of the same data — diagram and table share the time-window control and the same top-buyers slice. Click "View all buyers in research" to drill in with the matching date range.
No buyer activity in this window.
No buyer activity in this window.
Top buyers last 6 months · top 1
| Filer | Total spend | Disbursements |
|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND 1379198 |
$60,000 IE $30,000 · SB $30,000 |
6 |
Top buyers last 12 months · top 1
| Filer | Total spend | Disbursements |
|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND 1379198 |
$160,000 IE $80,000 · SB $80,000 |
16 |
Top buyers last 18 months · top 1
| Filer | Total spend | Disbursements |
|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND 1379198 |
$250,000 IE $130,000 · SB $120,000 |
25 |
Top buyers last 24 months · top 1
| Filer | Total spend | Disbursements |
|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND 1379198 |
$370,000 IE $190,000 · SB $180,000 |
37 |
By party
| Party | Amount | % |
|---|---|---|
| Democratic | $0 | 0.00% |
| Republican | $0 | 0.00% |
| Non-partisan | $183,609,595 | 100.00% |
Part III Reference tables
Full all-time and cycle-to-date data.
Money flow through this vendor
Where their ad buys point
IE payers (left) → races the buys targeted (right) · independent-expenditure filings onlyNo activity in the last 1 months.
No activity in the last 3 months.
Cycle-over-cycle trajectory
current cycle earlier election cycle off-cycle year quarterly · 7 years
| Year | Q | Cycle | Total | Txns | Top buyer · share | Top category · share | Cum. (cycle) | YoY % |
|---|---|---|---|---|---|---|---|---|
| 2020 | Q1 | 2020 | $37K | 3 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $37K | — |
| 2020 | Q2 | 2020 | $12K | 1 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $49K | — |
| 2021 | Q1 | 2020 | $48K | 4 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $96K | — |
| 2021 | Q2 | 2020 | $24K | 2 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $120K | — |
| 2021 | Q3 | 2020 | $12K | 1 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $132K | — |
| 2021 | Q4 | 2020 | $12K | 1 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $144K | — |
| 2022 | Q1 | 2022 | $48K | 4 | PHARMACEUTICAL RESEARCH AND… 75% | Other / Unclassified 100% | $48K | +30% |
| 2022 | Q2 | 2022 | $12K | 1 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $60K | -2% |
| 2022 | Q3 | 2022 | $24K | 2 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $83K | — |
| 2023 | Q1 | 2022 | $55K | 5 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $138K | +14% |
| 2023 | Q2 | 2022 | $33K | 3 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $171K | +37% |
| 2024 | Q1 | 2024 | $5K | 1 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $5K | -89% |
| 2024 | Q2 | 2024 | $10K | 2 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $15K | -16% |
| 2025 | Q1 | 2024 | $50K | 5 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $65K | -8% |
| 2025 | Q2 | 2024 | $50K | 5 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 100% | $115K | +53% |
| 2026 | Q1 | 2026 | $50K | 5 | PHARMACEUTICAL RESEARCH AND… 100% | Other / Unclassified 20% | $50K | +900% |
| 2026 | Q2 | 2026 | $30K | 3 | PHARMACEUTICAL RESEARCH AND… 100% | — | $80K | +200% |
Revenue by service category
No category revenue in this window.
No category revenue in this window.
No category revenue in this window.
No category revenue in this window.
No category revenue in this window.
No category revenue in this window.
| Category | Total spend | Txns | Avg check | % of total | Top buyer · share | Last paid |
|---|---|---|---|---|---|---|
| Other / Unclassified | $79,544,800 | 86 | $925K | 94.6% | PHARMACEUTICAL RESEARCH AND… 47% | 7mo ago |
| Contributions & Transfers | $4,548,500 | 2 | $2.27M | 5.4% | PHARMACEUTICAL RESEARCH AND… 100% | 21y ago |
Client retention
Sticky-relationship signal: how many clients keep coming back across cycles vs one-time buyers.
| Client | Cycles | All-time spend | Txns | First paid | Last paid |
|---|---|---|---|---|---|
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND | 3 | $41,795,600 | 24 | 2005-02-08 | 2022-03-15 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND | 6 | $32,489,600 | 67 | 2015-09-22 | 2026-05-08 |
Geographic concentration
Where this vendor's clients are based — federal committees by state, plus implicit jurisdiction for CA and TX state filers.
| State | Total spend | % of revenue | Clients | |
|---|---|---|---|---|
| CA | $84,163,300 | 100.0% | 3 |
Notable disbursements
5 largest all-time · 5 largest in the current cycle · 5 most recent. Each row earns its place.